| RS2040672480 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 4 |
| RS2040679706 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group P, Fanconi anemia complementation group P |
| RS2040679845 |
MORC2
|
Health Risk |
Likely pathogenic |
Developmental delay, impaired growth |
| RS2040680054 |
MORC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Developmental delay |
| RS2040682065 |
TGM1
|
Health Risk |
Likely pathogenic |
Autosomal recessive congenital ichthyosis 1, Autosomal recessive congenital ichthyosis 1 |
| RS2040683256 |
IFT140
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 80, Retinitis pigmentosa 80 |
| RS2040685752 |
IFT140
|
Health Risk |
Likely pathogenic |
Saldino-Mainzer syndrome, Retinitis pigmentosa 80 |
| RS2040686112 |
SLX4
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia |
| RS2040709857 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Cardiomyopathy |
| RS2040710629 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2040711393 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2040714340 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2040714896 |
DMD
|
Health Risk |
Pathogenic |
Colorectal cancer, Colorectal cancer |
| RS2040714903 |
TRIP12
|
Health Risk |
Likely pathogenic |
Clark-Baraitser syndrome, Clark-Baraitser syndrome |
| RS2040719776 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group P, Fanconi anemia complementation group P |
| RS2040719850 |
SLX4
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group P, Fanconi anemia |
| RS2040730164 |
TGM1
|
Health Risk |
Likely pathogenic |
Autosomal recessive congenital ichthyosis 1, Autosomal recessive congenital ichthyosis 1 |
| RS2040735453 |
SPECC1L
|
Health Risk |
Pathogenic |
Teebi hypertelorism syndrome 1, Teebi hypertelorism syndrome 1 |
| RS2040736026 |
TGM1
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 1, Autosomal recessive congenital ichthyosis 1 |
| RS2040737476 |
SPECC1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2040737996 |
TGM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive congenital ichthyosis 1, Autosomal recessive congenital ichthyosis 1 |
| RS2040774076 |
TGM1
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 1, Autosomal recessive congenital ichthyosis 1 |
| RS2040782954 |
TGM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive congenital ichthyosis 1, Autosomal recessive congenital ichthyosis 1 |
| RS2040788600 |
SLX4
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2040791482 |
TGM1
|
Health Risk |
Pathogenic |
— |
| RS2040794617 |
TGM1
|
Health Risk |
Likely pathogenic |
— |
| RS2040795178 |
TGM1
|
Health Risk |
Likely pathogenic |
— |
| RS2040811962 |
TGM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive congenital ichthyosis 1, Autosomal recessive congenital ichthyosis 1 |
| RS2040815760 |
TGM1
|
Health Risk |
Likely pathogenic |
Autosomal recessive congenital ichthyosis 1, Autosomal recessive congenital ichthyosis 1 |
| RS2040816609 |
TBK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 |
| RS2040817364 |
MORC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2Z, Developmental delay |
| RS2040818118 |
TGM1
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 1, Autosomal recessive congenital ichthyosis 1 |
| RS2040821014 |
DMD
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 3B, Duchenne muscular dystrophy |
| RS2040821117 |
TGM1
|
Health Risk |
Pathogenic |
— |
| RS2040843894 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2040844773 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
FANCA-related disorder, Fanconi anemia |
| RS2040845588 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2040846500 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2040847223 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2040847430 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2040852683 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS2040853392 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS2040853528 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2040855193 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2040857188 |
ELAC2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 17, Combined oxidative phosphorylation defect type 17 |
| RS2040857662 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2040859131 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2040861554 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2040862241 |
SNF8
|
Health Risk |
Pathogenic |
SNF8-associated disease, Developmental and epileptic encephalopathy 115 |
| RS2040866242 |
SYNJ1
|
Health Risk |
Likely pathogenic |
Early-onset Parkinson disease 20, Early-onset Parkinson disease 20 |
| RS2040867555 |
PIEZO2
|
Health Risk |
Likely pathogenic |
Congenital ichthyosiform erythroderma, Exocrine pancreatic insufficiency |
| RS2040876556 |
KIAA0586
|
Health Risk |
Pathogenic |
Joubert syndrome 23, Joubert syndrome 23 |
| RS2040913777 |
SYNJ1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 53 |
| RS2040931363 |
HSD11B2
|
Health Risk |
Pathogenic |
— |
| RS2040932099 |
TBK1
|
Health Risk |
Pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 |
| RS2040932336 |
HSD11B2
|
Health Risk |
Pathogenic |
— |
| RS2040936942 |
ELAC2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 17, Combined oxidative phosphorylation defect type 17 |
| RS2040937055 |
ELAC2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 17, Combined oxidative phosphorylation defect type 17 |
| RS2040942337 |
ELAC2
|
Health Risk |
Likely pathogenic |
Combined oxidative phosphorylation defect type 17, Combined oxidative phosphorylation defect type 17 |
| RS2040973121 |
CDK5RAP2
|
Health Risk |
Likely pathogenic |
Microcephaly 3, primary |
| RS2040979235 |
HSD11B2
|
Health Risk |
Pathogenic |
Apparent mineralocorticoid excess, Apparent mineralocorticoid excess |
| RS2040982837 |
ARMC9
|
Health Risk |
Likely pathogenic |
— |
| RS2040987609 |
TRIM37
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2040998358 |
MYH11
|
Health Risk |
Likely pathogenic |
Aortic aneurysm, familial thoracic 4 |
| RS2041000390 |
MYH11
|
Health Risk |
Pathogenic |
Aortic aneurysm, familial thoracic 4 |
| RS2041000812 |
SLC12A1
|
Health Risk |
Pathogenic |
— |
| RS2041013413 |
SNF8
|
Health Risk |
Pathogenic |
SNF8-associated disease, Developmental and epileptic encephalopathy 115 |
| RS2041024132 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2041025786 |
CEP164
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2041026343 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS2041026878 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS2041037870 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS2041038603 |
CEP164
|
Health Risk |
Likely pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS2041040360 |
DMD
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 3B, Dilated cardiomyopathy 3B |
| RS2041065544 |
FAH
|
Health Risk |
Likely pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2041065623 |
ELAC2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 17, Combined oxidative phosphorylation defect type 17 |
| RS2041065794 |
FAH
|
Health Risk |
Likely pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2041065908 |
FAH
|
Health Risk |
Pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2041066220 |
FAH
|
Health Risk |
Likely pathogenic |
— |
| RS2041085400 |
ELAC2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 17, Combined oxidative phosphorylation defect type 17 |
| RS2041086288 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 4 |
| RS2041090208 |
HOGA1
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS2041090817 |
MYH11
|
Health Risk |
Pathogenic |
Aortic aneurysm, familial thoracic 4 |
| RS2041094594 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS2041095238 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS2041095858 |
PYCR1
|
Health Risk |
Likely pathogenic |
Wiedemann-Rautenstrauch-like progeroid syndrome, Wiedemann-Rautenstrauch-like progeroid syndrome |
| RS2041095962 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2041096125 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS2041098068 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2041098364 |
PYCR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive cutis laxa type 2B, Autosomal recessive cutis laxa type 2B |
| RS2041099865 |
CEP164
|
Health Risk |
Likely pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS2041101017 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS2041101553 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2041101804 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2041102320 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS2041104962 |
HOGA1
|
Health Risk |
Pathogenic |
— |
| RS2041105506 |
HOGA1
|
Health Risk |
Pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS2041114940 |
FAH
|
Health Risk |
Pathogenic/Likely pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2041122746 |
VPS33B
|
Health Risk |
Pathogenic |
Arthrogryposis, renal dysfunction |
| RS2041131954 |
FAH
|
Health Risk |
Pathogenic |
Tyrosinemia type I, Tyrosinemia type I |